Mild–moderate | Severe | Life-threatening | |
Description | All of: Can walk, speak whole sentences in one breath (younger children can speak in phrases) SpO2 (room air) >94% | Any of: Unable to complete sentences in one breath due to breathlessness Use of accessory muscles of neck or intercostal muscles/tracheal tug/subcostal recession during inspiration Obvious respiratory distress SpO2 (room air) ≤94% | Any of: Reduced consciousness/collapse, exhaustion Cyanosis Poor respiratory effort SpO2 (room air) <90% Poor respiratory effort, soft/absent breath sounds
|
Immediate treatment | Give salbutamol 4–12 actuations (100 microg per actuation) via pMDI and spacer (tidal breathing) Repeat salbutamol 4–12 actuations every 20–30 minutes for the first hour, if needed (sooner if needed) | Start bronchodilators: Salbutamol 12 actuations (100 microg per actuation) via pMDI and spacer (tidal breathing). If patient cannot use spacer, give 5 mg nebule via nebuliser. Ipratropium 8 actuations (21 microg/actuation) via pressurised metered-dose inhaler and spacer every 20 minutes for first hour. Start oxygen supplementation if SpO2 <92% on room air and titrate to target SpO2 92–96% Repeat bronchodilators 4–6 hourly for 24 hours. If salbutamol delivered via nebuliser, add 500 microg ipratropium to nebulised solution every 20 minutes for first hour. Repeat 4–6 hourly. | Arrange immediate transfer to higher-level care Start bronchodilators: Salbutamol 2 x 5 mg nebules via continuous nebulisation driven by oxygen Ipratropium 500 microg ipratropium added to nebulised solution every 20 minutes for first hour. Maintain SpO2 92–96% Repeat bronchodilators 4–6 hourly. When dyspnoea improves, consider changing to salbutamol via pMDI plus spacer or intermittent nebuliser
|
Additional information
pMDI: pressurised metered-dose inhaler; SpO2: oxygen saturation